Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

The Epidemiology of Otosclerosis in a British Cohort.

Crompton M, Cadge BA, Ziff JL, Mowat AJ, Nash R, Lavy JA, Powell HRF, Aldren CP, Saeed SR, Dawson SJ.

Otol Neurotol. 2019 Jan;40(1):22-30. doi: 10.1097/MAO.0000000000002047.

2.

Evidence of distinct RELN and TGFB1 genetic associations in familial and non-familial otosclerosis in a British population.

Mowat AJ, Crompton M, Ziff JL, Aldren CP, Lavy JA, Saeed SR, Dawson SJ.

Hum Genet. 2018 May;137(5):357-363. doi: 10.1007/s00439-018-1889-9. Epub 2018 May 4.

3.

Evaluation of in-situ fatty acid extraction protocols for the analysis of staphylococcal cell membrane associated fatty acids by gas chromatography.

Crompton MJ, Dunstan RH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 May 1;1084:80-88. doi: 10.1016/j.jchromb.2018.03.018. Epub 2018 Mar 10.

PMID:
29574290
4.

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.

Crompton M, Purnell T, Tyrer HE, Parker A, Ball G, Hardisty-Hughes RE, Gale R, Williams D, Dean CH, Simon MM, Mallon AM, Wells S, Bhutta MF, Burton MJ, Tateossian H, Brown SDM.

PLoS Genet. 2017 Aug 14;13(8):e1006969. doi: 10.1371/journal.pgen.1006969. eCollection 2017 Aug.

5.

Sweat Facilitated Amino Acid Losses in Male Athletes during Exercise at 32-34°C.

Dunstan RH, Sparkes DL, Dascombe BJ, Macdonald MM, Evans CA, Stevens CJ, Crompton MJ, Gottfries J, Franks J, Murphy G, Wood R, Roberts TK.

PLoS One. 2016 Dec 9;11(12):e0167844. doi: 10.1371/journal.pone.0167844. eCollection 2016.

6.

Changes in the Cytoplasmic Composition of Amino Acids and Proteins Observed in Staphylococcus aureus during Growth under Variable Growth Conditions Representative of the Human Wound Site.

Alreshidi MM, Dunstan RH, Gottfries J, Macdonald MM, Crompton MJ, Ang CS, Williamson NA, Roberts TK.

PLoS One. 2016 Jul 21;11(7):e0159662. doi: 10.1371/journal.pone.0159662. eCollection 2016.

7.

Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Ziff JL, Crompton M, Powell HR, Lavy JA, Aldren CP, Steel KP, Saeed SR, Dawson SJ.

Hum Mol Genet. 2016 Jun 15;25(12):2393-2403. Epub 2016 Apr 7.

8.

A new model for non-typeable Haemophilus influenzae middle ear infection in the Junbo mutant mouse.

Hood D, Moxon R, Purnell T, Richter C, Williams D, Azar A, Crompton M, Wells S, Fray M, Brown SD, Cheeseman MT.

Dis Model Mech. 2016 Jan;9(1):69-79. doi: 10.1242/dmm.021659. Epub 2015 Nov 26.

9.

Tubulin modulating antifungal and antiproliferative pyrazinone derivatives.

Taggi AE, Stevenson TM, Bereznak JF, Sharpe PL, Gutteridge S, Forman R, Bisaha JJ, Cordova D, Crompton M, Geist L, Kovacs P, Marshall E, Sheth R, Stavis C, Tseng CP.

Bioorg Med Chem. 2016 Feb 1;24(3):435-43. doi: 10.1016/j.bmc.2015.08.038. Epub 2015 Aug 28.

PMID:
26386818
10.

Outcomes and metrics for antimicrobial stewardship: survey of physicians and pharmacists.

Bumpass JB, McDaneld PM, DePestel DD, Lamp KC, Chung TJ, McKinnon PS, Crompton MG, Hermsen ED.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S108-11. doi: 10.1093/cid/ciu545.

PMID:
25261537
11.

Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.

Joseph WS, Quast T, Cogo A, Crompton MG, Yoon MJ, Lamp KC, Culshaw D, Chaves RL.

J Am Podiatr Med Assoc. 2014 Mar;104(2):159-68. doi: 10.7547/0003-0538-104.2.159.

PMID:
24725036
12.

Small changes in environmental parameters lead to alterations in antibiotic resistance, cell morphology and membrane fatty acid composition in Staphylococcus lugdunensis.

Crompton MJ, Dunstan RH, Macdonald MM, Gottfries J, von Eiff C, Roberts TK.

PLoS One. 2014 Apr 8;9(4):e92296. doi: 10.1371/journal.pone.0092296. eCollection 2014.

13.

Development of a complex amino acid supplement, Fatigue Reviva™, for oral ingestion: initial evaluations of product concept and impact on symptoms of sub-health in a group of males.

Dunstan RH, Sparkes DL, Roberts TK, Crompton MJ, Gottfries J, Dascombe BJ.

Nutr J. 2013 Aug 8;12:115. doi: 10.1186/1475-2891-12-115.

14.

What have we learned from murine models of otitis media?

Tyrer HE, Crompton M, Bhutta MF.

Curr Allergy Asthma Rep. 2013 Oct;13(5):501-11. doi: 10.1007/s11882-013-0360-1. Review.

PMID:
23775349
15.

Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.

Soloviev M, Esteves MP, Amiri F, Crompton MR, Rider CC.

PLoS One. 2013;8(2):e57327. doi: 10.1371/journal.pone.0057327. Epub 2013 Feb 27.

16.

A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes.

Dube H, Selwood D, Malouitre S, Capano M, Simone MI, Crompton M.

Biochem J. 2012 Feb 1;441(3):901-7. doi: 10.1042/BJ20111301.

17.

Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes.

Tupper J, Crompton MR, Harvey AJ.

Arch Dermatol Res. 2011 May;303(4):293-7. doi: 10.1007/s00403-010-1118-4. Epub 2011 Jan 15.

18.
19.

Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.

Harvey AJ, Pennington CJ, Porter S, Burmi RS, Edwards DR, Court W, Eccles SA, Crompton MR.

Am J Pathol. 2009 Sep;175(3):1226-34. doi: 10.2353/ajpath.2009.080811. Epub 2009 Aug 6.

20.

RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology.

Ghahramani Seno MM, Graham IR, Athanasopoulos T, Trollet C, Pohlschmidt M, Crompton MR, Dickson G.

Hum Mol Genet. 2008 Sep 1;17(17):2622-32. doi: 10.1093/hmg/ddn162. Epub 2008 May 28.

PMID:
18511456
21.

Evaluating cytochrome c diffusion in the intermembrane spaces of mitochondria during cytochrome c release.

Gillick K, Crompton M.

J Cell Sci. 2008 Mar 1;121(Pt 5):618-26. doi: 10.1242/jcs.021303. Epub 2008 Feb 5.

23.
24.

Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Kasprzycka M, Majewski M, Wang ZJ, Ptasznik A, Wysocka M, Zhang Q, Marzec M, Gimotty P, Crompton MR, Wasik MA.

Am J Pathol. 2006 May;168(5):1631-41.

26.

RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killing by 17-allylamino-17-demethoxygeldanamycin.

Withey JM, Harvey AJ, Crompton MR.

Leuk Res. 2006 May;30(5):553-60. Epub 2005 Nov 2.

PMID:
16260034
27.

Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.

Withey JM, Marley SB, Kaeda J, Harvey AJ, Crompton MR, Gordon MY.

Br J Haematol. 2005 May;129(3):377-80.

PMID:
15842662
28.

Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis.

Li Y, Johnson N, Capano M, Edwards M, Crompton M.

Biochem J. 2004 Oct 1;383(Pt 1):101-9.

29.

The Privacy Imperative for a Successful Health Connect.

Crompton M.

Health Inf Manag. 2004 Jul;33(1):3-4. doi: 10.1177/183335830403300102. No abstract available.

PMID:
29338528
30.

Comparison of neuroplastin and synaptic marker protein expression in acute and cultured organotypic hippocampal slices from rat.

Buckby LE, Mummery R, Crompton MR, Beesley PW, Empson RM.

Brain Res Dev Brain Res. 2004 May 19;150(1):1-7.

PMID:
15126032
31.

The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges.

Harvey AJ, Crompton MR.

Anticancer Drugs. 2004 Feb;15(2):107-11. Review.

PMID:
15075665
32.

Mitochondria and aging: a role for the permeability transition?

Crompton M.

Aging Cell. 2004 Feb;3(1):3-6. Review.

34.

On the involvement of mitochondrial intermembrane junctional complexes in apoptosis.

Crompton M.

Curr Med Chem. 2003 Aug;10(16):1473-84. Review.

PMID:
12871121
35.

Increased susceptibility of striatal mitochondria to calcium-induced permeability transition.

Brustovetsky N, Brustovetsky T, Purl KJ, Capano M, Crompton M, Dubinsky JM.

J Neurosci. 2003 Jun 15;23(12):4858-67.

36.

Issues of consent and privacy affecting the functioning of ASERNIP-S.

Crompton M.

ANZ J Surg. 2002 Aug;72(8):535-6. No abstract available.

PMID:
12190720
37.

Biphasic translocation of Bax to mitochondria.

Capano M, Crompton M.

Biochem J. 2002 Oct 1;367(Pt 1):169-78.

38.

Mitochondrial intermembrane junctional complexes and their involvement in cell death.

Crompton M, Barksby E, Johnson N, Capano M.

Biochimie. 2002 Feb-Mar;84(2-3):143-52. Review.

PMID:
12022945
39.

Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells.

Capano M, Virji S, Crompton M.

Biochem J. 2002 Apr 1;363(Pt 1):29-36.

42.
43.

The mitochondrial permeability transition pore.

Crompton M, Virji S, Doyle V, Johnson N, Ward JM.

Biochem Soc Symp. 1999;66:167-79. Review.

PMID:
10989666
44.

A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.

Mitchell PJ, Sara EA, Crompton MR.

Oncogene. 2000 Aug 31;19(37):4273-82.

45.

Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis.

Crompton M.

Curr Opin Cell Biol. 2000 Aug;12(4):414-9. Review.

PMID:
10873816
46.

Import and processing of heart mitochondrial cyclophilin D.

Johnson N, Khan A, Virji S, Ward JM, Crompton M.

Eur J Biochem. 1999 Jul;263(2):353-9.

47.

The mitochondrial permeability transition pore and its role in cell death.

Crompton M.

Biochem J. 1999 Jul 15;341 ( Pt 2):233-49. Review.

48.

Evidence that cyclophilin-A protects cells against oxidative stress.

Doyle V, Virji S, Crompton M.

Biochem J. 1999 Jul 1;341 ( Pt 1):127-32.

49.

Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.

Burke F, Smith PD, Crompton MR, Upton C, Balkwill FR.

Br J Cancer. 1999 Jun;80(8):1236-44.

50.

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.

Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ, Crook T.

Oncogene. 1999 Apr 15;18(15):2451-9.

Supplemental Content

Loading ...
Support Center